BRESAGEN INC has a total of 20 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are FUJIFILM CELLULAR DYNAMICS INC, R BIO CO LTD and CELLULAR DYNAMICS INT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 | |
#3 | Canada | 3 | |
#4 | Australia | 2 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Schulz Thomas C | 10 |
#2 | Robins Allan J | 9 |
#3 | Condie Brian | 8 |
#4 | Mitalipova Maisam | 5 |
#5 | Lyons Ian | 5 |
#6 | Robins Allan | 4 |
#7 | Bieberich Erhard | 4 |
#8 | Condie Brian G | 2 |
#9 | Noggle Scott A | 2 |
#10 | Brandon Eugene P | 2 |
Publication | Filing date | Title |
---|---|---|
CA2703116A1 | Feeder-free pluripotent stem cell media containing human serum | |
WO2007147165A2 | Human cancer stem cell culture compositions comprising erbb2 variants and methods of use thereof | |
WO2007002210A2 | Embryonic stem cell culture compositions and methods of use thereof | |
WO2004090110A2 | Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway | |
AU2003303741A1 | Compositions and methods for neural cell production and stabilization | |
US2006014280A1 | Compositions and methods for enrichment of neural stem cells using ceramide analogs | |
CA2456981A1 | Alternative compositions and methods for the culture of stem cells |